MedTrace Logo

Closing the Loop in Adults With Type 1 Diabetes

NCT00910767 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2009-09-17

No results posted yet for this study

Summary

The main objective of this study is to evaluate the feasibility of closed loop insulin pump therapy to improve overnight glucose control in adults with type 1 diabetes.

Conditions

Interventions

DEVICE

Conventional insulin pump delivery

Subcutaneous delivery of Novorapid insulin according to usual pump regime

DEVICE

Closed loop

Subcutaneous delivery of Novorapid insulin, dose calculated by control algorithm, based on continuous glucose sensor readings

Sponsors & Collaborators

  • Cambridge University Hospitals NHS Foundation Trust

    collaborator OTHER

  • Diabetes UK

    collaborator OTHER

  • University of Cambridge

    lead OTHER

Principal Investigators

  • Mark L Evans, MD FRCP · University of Cambridge, UK

  • Roman Hovorka, PhD · University of Cambridge, UK

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-02-28
Primary Completion
2009-07-31
Completion
2009-07-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00910767 on ClinicalTrials.gov